TD Private Client Wealth’s Halozyme HALO Stock Holding History

TD Private Client Wealth’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.2K	Buy	173 +119	+220%	+$8.39K	﹤0.01%	1087
2025 Q4	$3.63K	Buy	54 +2	+4%	+$135	﹤0.01%	1200
2025 Q3	$3.81K	Hold	52	–	–	﹤0.01%	1170
2025 Q2	$2.71K	Sell	52 -24	-32%	-$1.37K	﹤0.01%	1186
2025 Q1	$4.85K	Sell	76 -258	-77%	-$15K	﹤0.01%	1084
2024 Q4	$16K	Buy	334 +296	+779%	+$15.2K	﹤0.01%	1002
2024 Q3	$2.17K	Buy	38 +16	+73%	+$917	﹤0.01%	1175
2024 Q2	$1.15K	Buy	+22	New	+$965	﹤0.01%	1165
2021 Q4	–	Sell	-24	Closed	-$976	–	1206
2021 Q3	$976	Hold	24	–	–	﹤0.01%	1106
2021 Q2	$1.09K	Hold	24	–	–	﹤0.01%	1102
2021 Q1	$1K	Hold	24	–	–	﹤0.01%	1070
2020 Q4	$1.02K	Hold	24	–	–	﹤0.01%	1016
2020 Q3	$631	Hold	24	–	–	﹤0.01%	1008
2020 Q2	$643	Hold	24	–	–	﹤0.01%	1001
2020 Q1	$432	Hold	24	–	–	﹤0.01%	983
2019 Q4	$426	Buy	+24	New	+$416	﹤0.01%	1006

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TD Private Client Wealth's HALO Position: Q1 2026 in Review

TD Private Client Wealth increased its Halozyme (HALO) stake by 220% in Q1 2026, buying an estimated $8.39K and bringing the position to 173 shares worth $11.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

TD Private Client Wealth first reported a position in HALO in Q4 2019 and has held it in 16 quarters since. The position peaked at $16K in Q4 2024. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

TD Private Client Wealth held 173 shares of Halozyme worth $11.2K as of Q1 2026.
TD Private Client Wealth bought 119 Halozyme shares in Q1 2026, an estimated $8.39K.
Halozyme made up ﹤0.01% of TD Private Client Wealth's portfolio in Q1 2026, its #1087 holding.
TD Private Client Wealth first reported a position in Halozyme in Q4 2019 and has held it in 16 quarters since.
TD Private Client Wealth's Halozyme position peaked at $16K in Q4 2024.
634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on TD Private Client Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.